Skip to main content.


Picture of William Heisel

I wrote a piece recently for Health News Review about conflicts of interest. The original post is below, followed by more great examples of writers describing unexpected conflicts in detail.

Picture of Ricki Lewis

Correcting a genetic defect before birth sounds like a great idea, but I'm uncomfortable with how we get there.

Picture of William Heisel

FDA regulator Paul T. Hardy blew the whistle on problems with a Kodak mammography system — and got fired for his trouble. Here's what happened next.

Picture of Barbara Feder Ostrov

As investigators finally trace a deadly listeria outbreak to melons from a Colorado packing shed, food safety expert Douglas Powell offers timely advice on covering food safety issues.

Picture of William Heisel

A new company aims to clean up the FDA's messy data for reporting drug adverse events and market it to pharma and other businesses. Health reporters can benefit from the company's work, too.

Picture of William Heisel

Why is the FDA'S adverse events drug database in such a shambles? Scientist Keith Hoffman explains — and talks about how his company has found a business opportunity in that messy data.

Picture of R. Jan Gurley

A new start-up is mining the FDA's adverse event data for medications and finding potentially dangerous patterns that the regulatory agency hasn't addressed — but should.

Picture of William Heisel

Shannon Brownlee offers a not-so-modest proposal for universities to stamp out pharma ghostwriting benefiting researchers.

Picture of Laura Newman

Millions of American women were put on hormone replacement therapy before science evaluated the benefits and harms. Will men over 45 try testosterone replacement therapy too? Aggressive marketing of testosterone is on the rise.

Picture of Jeff  Kelly Lowenstein

A new reporting project will focus on community health challenges facing predominantly Latino communities in Chicago and the Midwest.



Follow Us



CHJ Icon